Future therapies for the treatment of bladder neoplasms.
The last several decades have witnessed an exponential growth in the understanding of the biology of human neoplasms. As a consequence, a number of new strategies for the treatment of urologic cancers are currently under evaluation. We provide an overview of promising new treatment approaches as they apply to the management of transitional cell carcinoma of the urinary bladder.
See
W A
WA
Department of Urology, University of Iowa, Iowa City 52242-1089, USA. william-see/uiowa.edu
Berman
C J
CJ
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001695:Biology; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005544:Forecasting; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D009130:Muscle, Smooth / Q000473:pathology; D009361:Neoplasm Invasiveness; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents